四川升和药业股份有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
223
NMPA:223
Drug Approvals
Fasudil Hydrochloride Injection
- Product Name
- 盐酸法舒地尔注射液
- Approval Number
- 国药准字H20133339
- Approval Date
- Aug 23, 2023
NMPA
Levofloxacin Lactate Dispersible Tablets
- Product Name
- 乳酸左氧氟沙星分散片
- Approval Number
- 国药准字H20080278
- Approval Date
- Sep 20, 2022
NMPA
Diammonium Glycyrrhizinate Capsules
- Product Name
- 甘草酸二铵胶囊
- Approval Number
- 国药准字H20123164
- Approval Date
- Apr 8, 2022
NMPA
Promethazine Hydrochloride Tablets
- Product Name
- 盐酸异丙嗪片
- Approval Number
- 国药准字H51020570
- Approval Date
- Jun 16, 2021
NMPA
Sterile Water for Injection
- Product Name
- 灭菌注射用水
- Approval Number
- 国药准字H51023068
- Approval Date
- Jun 16, 2021
NMPA
Sterile Water for Injection
- Product Name
- 灭菌注射用水
- Approval Number
- 国药准字H51023069
- Approval Date
- Jun 16, 2021
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 23
- Next
Clinical Trials
No trials found
News
No news found